Pfizer’s vaccine against respiratory syncytial virus (RSV) may be associated with certain health problems in pregnant women, including hypertensive disorders, researchers said in a study published on April 21.
Ashley Michnick, a research scientist at Harvard Medical School, and researchers with Pfizer and other entities analyzed data from five systems, including CVS Health and Kaiser Permanente Northwest.
